However, the expression of PD-L1 in tumor tissues should not be used as criteria to exclude patients from the treatment with either anti-PD-1 or anti- PD-L1 antibodies, as patients whose tumors were stained as PD-L1 negative can have objective responses. The gene discussed is CD274; the disease is neoplasm.